New Report “Market Access Brazil: Unlocking Pharma Potential” Now Available at

05 Sep 2011 • by Natalie Aster
New Report “Market Access Brazil: Unlocking Pharma Potential” Now Available at

LONDON – Brazil is a rapidly expanding economy with a whole row of new project launches and a definite willingness to encourage a wide stream of investments into the country, pharmaceutical industry being part of the investment programme. However there are concers and challenges surrounding this path. Complex tax laws, pricing procedures, slow product approvals and linguistic barriers hinder the development of the pharmaceutical market. has indicated a willingness to encourage long-term foreign investment in the pharmaceutical industry. Moreover government-favoured generics and low-priced illegally-traded drugs (25% of the total supply on the pharmaceutical market in Brazil) are impeding the presence endeavors and pose critical competition.

New market research report Market Access Brazil: Unlocking Pharma Potentialworked out by FirstWord offers an in-depth examination of health care and pharmaceutical industry in Brazil. It addresses critical issues such as responsibilities and the role of the National Health Surveillance Agency to consumer trends, the latest patent protection issues, the role of generics and ongoing battle over intellectual property. Covering interviews with experts, financial comparatives and updates from multinationals in the region, the report presents a full-view picture and analysis of Brazil’s pharmaceutical industry.

Report Details:

Title: Market Access Brazil: Unlocking Pharma Potential
Published: July, 2011
Pages: 38
Price: US$ 795

Report Contents:

Executive Summary
The Brazilian pharmaceutical market
  Healthcare provision
  Health sector responsibilities
    Principal pharmaceutical patent legislation
  Patent protection
    Pharmaceutical patent applications (Jan 2001-Jan 2011)
  Accessing the Brazilian pharmaceutical market
Trends in the Brazilian pharmaceutical market
  Prescription Data for Brazil, 2009/10
  Pharmaceuticals in Brazil, User Profile
    Pharmaceutical Production in Brazil by Type of Capital, 2010
  Intellectual Property
    Estimated Market Shares of the Top 10 Pharma Companies in Brazil, June 2011
  Licensing agreements
    Measures to ensure the legality of medicines in Brazil
    Interview with Marin Osorio, Senior Secretary, Ministry of Health
  Price control
    New reimbursement legislation
    Multiple trade marks
    The ’Pipeline Mechanism’
    Investing within a protectionist environment
  Establishing a presence in Brazil

To order the report or ask for free sample pages, please contact



The Market Publishers, Ltd.

Tanya Rezler

Tel: +44 208 144 6009

Fax: +44 207 900 3970